Have a personal or library account? Click to login
Serum Albumin Concentration and the Risk of Cardiovascular Disease and Acute Coronary Syndrome — a Narrative Review Cover

Serum Albumin Concentration and the Risk of Cardiovascular Disease and Acute Coronary Syndrome — a Narrative Review

Open Access
|Mar 2025

References

  1. Van Dronkelaar C, Tieland M, Cederholm T, Reijnierse EM, Weijs PJM, Kruizenga H. Malnutrition Screening Tools Are Not Sensitive Enough to Identify Older Hospital Patients with Malnutrition. Nutrients. 2023;15(24):5126. doi: 10.3390/nu15245126
  2. Schalk BW, Visser M, Bremmer MA, Penninx BW, Bouter LM, Deeg DJ. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am J Epidemiol. 2006;164(10):969–977. doi: 10.1093/aje/kwj312
  3. Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, et al. Health ABC Study. Serum albumin concentration and heart failure risk the Health, Aging, and Body Composition Study. Am Heart J. 2010;160(2):279–285. doi: 10.1016/j.ahj.2010.05.022
  4. Lyons O, Whelan B, Bennett K, O’Riordan D, Silke B. Serum albumin as an outcome predictor in hospital emergency medical admissions. Eur J Intern Med. 2010;21(1):17–20. doi: 10.1016/j.ejim.2009.10.010
  5. Arques S. Serum albumin and cardiovascular disease: State-of-the-art review. Annales de Cardiologie et d’Angéiologie. 2020;69(4):192–200. doi: 10.1016/j.ancard.2020.07.012
  6. Dorobanțu M, Halațiu VB, Gheorghe-Fronea O, et al. The Association between Apolipoprotein B, Cardiovascular Risk Factors and Subclinical Atherosclerosis-Findings from the SEPHAR National Registry on Hypertension in Romania. Int J Mol Sci. 2023;24(3):2813. doi: 10.3390/ijms24032813
  7. Kurtul A, Murat SN, Yarlioglues M, et al. Usefulness of serum albumin concentration to predict high coronary SYNTAX score and in-hospital mortality in patients with acute coronary syndrome. Angiology. 2016;67(1):34–40. doi: 10.1177/0003319715575220
  8. Oduncu V, Erkol A, Karabay CY, et al. The prognostic value of serum albumin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coron Artery Dis. 2013;24(2):88–94. doi: 10.1097/MCA.0b013e32835c46fd
  9. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55(4):820–829. doi: 10.1016/s0008-6363(02)00492-3
  10. Walley KR, McDonald TE, Wang Y, Dai S, Russell JA. Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia. Crit Care Med. 2003;31(1):187–194. doi: 10.1097/00003246-200301000-00029
  11. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–1787. doi: 10.1016/j.febslet.2008.04.057
  12. Anraku M, Chuang VT, Maruyama T, Otagiri M. Redox properties of serum albumin. Biochim Biophys Acta. 2013;1830(12):5465–5472. doi: 10.1016/j.bbagen.2013.04.036
  13. Paar M, Rossmann C, Nusshold C, et al. Anticoagulant action of low, physiologic, and high albumin levels in whole blood. PLoS One. 2017;12(8):e0182997. doi: 10.1371/journal.pone.0182997
  14. Plakht Y, Gilutz H, Shiyovich A. Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project. Int J Cardiol. 2016;219:20–24. doi: 10.1016/j.ijcard.2016.05.067
  15. Czinege M, Nyulas V, Halațiu VB, Țolescu C, Cojocariu LO, et al. Interrelationship between Altered Left Ventricular Ejection Fraction and Nutritional Status in the Post-Acute Myocardial Infarction Patient. Nutrients. 2024;16(13):2142. doi: 10.3390/nu16132142
  16. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation. 2002;106(23):2919–2924. doi: 10.1161/01.cir.0000042673.07632.76
  17. Nihat P, Mustafa O, Mehmet AI, Bayram A. Prognostic Significance of Serum Albumin in Patients With Acute Coronary Syndrome. Angiology. 2020;71(10):903–908. doi: 10.1177/0003319720941747
  18. Famakin B, Weiss P, Hertzberg V, et al. Hypoalbuminemia predicts acute stroke mortality: Paul Coverdell Georgia Stroke Registry. J Stroke Cerebrovasc Dis. 2010;19(1):17–22. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.015
  19. Chien SC, Chen CY, Leu HB, et al. Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease. Int J Cardiol. 2017;241(15):1–5. doi: 10.1016/j.ijcard.2017.04.003
  20. Ancion A, Allepaerts S, Oury C, Gori AS, Piérard LA, Lancellotti P. Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESCHeart Fail. 2017;4(2):138–145. doi: 10.1002/ehf2.12128
  21. Rus V, Chitu M, Cernea S, et al. Altered nutritional status, inflammation and systemic vulnerability in patients with acute myocardial infarction undergoing percutaneous coronary revascularisation: A prospective study in a level 3 cardiac critical care unit. Nutr Diet. 2020;77(2):212–222. doi: 10.1111/1747-0080.12536
  22. Czinege M, Halațiu VB, Nyulas V, et al. Nutritional Status and Recurrent Major Cardiovascular Events Following Acute Myocardial Infarction—A Follow-Up Study in a Primary Percutaneous Coronary Intervention Center. Nutrients. 2024;16(7):1088. doi: 10.3390/nu16071088
  23. Novack V, Pencina M, Zahger D, et al. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS One. 2010;5(8):e12184. doi: 10.1371/journal.pone.0012184
  24. Yu Q, Wang Z, Ding X. Serum prealbumin as a predictor of adverse outcomes in patients with heart failure: asystematic review and metaanalysis. Biomarkers in Medicine. 2022;16(7):569–575. doi: 10.2217/bmm-2021-1065
  25. Jacob M, Paul O, Mehringer L, et al. Albumin augmentation improves the condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation. 2009;87(7):956–965. doi: 10.1097/TP.0b013e31819c83b5
  26. Avram L, Avram C, Olah P, et al. Knowledge about food additives among adults – pilot study. Progr Nutr. 2021;23(1). doi: 10.23751/pn.v23i1.10631
  27. Fanali G, di Masi A, Trezza V, et al. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33(3):209–290. doi: 10.1016/j.mam.2011.12.002
  28. Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;151(5):468–477. doi: 10.1093/oxfordjournals.aje.a010232
  29. Xu WH, Dong C, Rundek T, Elkind MS, Sacco RL. Serum albumin levels are associated with cardioembolic and cryptogenic ischemic strokes: Northern Manhattan Study. Stroke. 2014;45(4):973–978. doi: 10.1161/STROKEAHA.113.003835
  30. Arques S. Human serum albumin in cardiovascular diseases. Eur J Int Med. 2018;52:8–12. doi: 10.1016/j.ejim.2018.04.014
  31. Arques S, Pieri B, Biegle G, Roux E, Gelisse R, Jauffret B. Comparative value of B-type natriuretic peptide and serum albumin concentration in the prediction of in-hospital mortality in elderly patients admitted for acute severe heart failure. Ann Cardiol Angeiol (Paris). 2009;58(5):279–283. doi: 10.1016/j.ancard.2009.09.003
  32. Ronit A, Kirkegaard-Klitbo DM, Dohlmann TL, et al. Plasma albumin and incident cardiovascular disease: Results from the CGPS and an updated meta-analysis. Arterioscler Thromb Vasc Biol. 2020;40(2):473–482. doi: 10.1161/ATVBAHA.119.313681
  33. Liu G, Hu X, Long M, Du ZM, Li Y, Hu CH. Meta-analysis of the impact of pre-procedural serum albumin on mortality in patients undergoing thranscatheter aortic valve replacement. Int Heart J. 2020;61(1):67–76. doi: 10.1536/ihj.19-395
  34. Pignatelli P, Farcomeni A, Menichelli D, Pastori D, Violi F. Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and bayesian meta-regression analysis. Intern Emerg Med. 2020;15(1):135–143. doi: 10.1007/s11739-019-02204-2
  35. Peng W, Zhang C, Wang Z, Yang W. Prediction of all-cause mortality with hypoalbuminemia in patients with heart failure: a meta-analysis. Biomarkers. 2019;24(7):631–637. doi: 10.1080/1354750X.2019.1652686
  36. Zhu L, Chen M, Lin X. Serum albumin level for the prediction of all-cause mortality in acute coronary syndrome patients: a meta-analysis. Biosci Rep. 2020;40(1):BSR20190881. doi: 10.1042/BSR20190881
  37. Melenovsky V, Andersen MJ, Andress K, Reddy YN, Borlaug BA. Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications. Eur J Heart Fail. 2015;17(11):1161–1171. doi: 10.1002/ejhf.417
  38. González P, Héctor Luis M, Amezcua G, et al. Levels of High-Density Lipoprotein Cholesterol are Associated With Biomarkers of Inflammation in Patients With Acute Coronary Syndrome. Am J Cardiol. 2015;116(11):1651–1657. doi: 10.1016/j.amjcard.2015.09.009
  39. González-Pacheco H, Amezcua-Guerra LM, Sandoval J, et al. Prognostic implications of serum albumin levels in patients with acute coronary syndromes. Am J Cardiol. 2017;119(7):951–958. doi: 10.1016/j.amjcard.2016.11.054
  40. Aleksander K, Gerhard-Paul D, Rafael G, et al. Hypoalbuminaemia predicts outcomes in adult patients with congenital heart disease. Heart. 2015;101(9):699–705. doi: 10.1136/heartjnl-2014-306970
  41. Bhamidipati CM, LaPar DJ, Mehta GS, et al. Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting. Surgery. 2011;150(4):626–634. doi: 10.1016/j.surg.2011.07.056
  42. Reinhart WH. Fibrinogen-marker or mediator of vascular disease? Vasc Med. 2003;8(3):211–216. doi: 10.1191/1358863x03vm494ra
  43. Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320. doi: 10.1056/NEJMoa1107477
  44. Tabakcı MM, Gerin F, Sunbul M, et al. Relation of plasma fibrinogen level with the presence, severity, and complexity of coronary artery disease. Clin Appl Thromb Hemost. 2017;23(6):638–644. doi: 10.1177/1076029616629210
  45. Don BR, Kaysen GA. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437. doi: 10.1111/j.0894-0959.2004.17603.x
  46. Cetin M, Zencir C, Tasolar H, Baysal E, Balli M, Akturk E. The association of serum albumin with coronary slow flow. Wien Klin Wochenschr. 2014;126(15–16):468–473. doi: 10.1007/s00508-014-0559-8
  47. Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults. J Clin Med. 2023;12(3):1128. doi: 10.3390/jcm12031128
  48. Ryszard T, Janusz S, Magdalena Starek-S, Radosław T, Andrzej R. Prognostic significance of red cell distribution width and its relation to increased pulmonary pressure and inflammation in acute heart failure. Cardiology Journal. 2020;27(4):394–403. doi: 10.5603/CJ.a2018.0103
  49. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155(5):883–889. doi: 10.1016/j.ahj.2007.11.043
  50. Filippatos GS, Desai RV, Ahmed MI, et al. Hypoalbuminaemia and incident heart failure in older adults. Eur J Heart Fail. 2011;13(10):1078–1086. doi: 10.1093/eurjhf/hfr088
  51. Bonilla-Palomas JL, Gamez-Lopez AL, Moreno-Conde M, et al. Hypoalbuminemia in acute heart failure patients: Causes and its impact on hospital and long-term mortality. J Card Fail. 2014;20(5):350–358. doi: 10.1016/j.cardfail.2014.01.016
  52. Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail. 2011;17(6):451–458. doi: 10.1016/j.cardfail.2011.02.010
  53. Liu M, Chan CP, Yan BP, et al. Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2012;14(1):39–44. doi: 10.1093/eurjhf/hfr154
  54. Proboteanu P, Caloian B, Pop D. Heart Failure as the First Clinical Manifestation of Basedow’s Disease. Journal of Cardiovascular Emergencies. 2024;10(2):78–82. doi: 10.2478/jce-2024-0012
  55. Marfella R, Siniscalchi M, Esposito K, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care. 2003;26(11):3129–3135. doi: 10.2337/diacare.26.11.3129
  56. Danielski M, Ikizler TA, McMonagle E, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis Off J Natl Kidney Found. 2003;42(2):286–294. doi: 10.1016/s0272-6386(03)00653-x
  57. Van der Pol A, Van Gilst WH, Voors AA, Van der Meer P. Treating oxidative stress in heart failure: Past, present and future. Eur J Heart Fail. 2019;21(4):425–435. doi: 10.1002/ejhf.1320
  58. Ancion A, Allepaerts S, Oury C, Gori AS, Piérard LA, Lancellotti P. Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail. 2017;4(2):138–145. doi: 10.1002/ehf2.12128
  59. Sajad RM, Bharathi, Lakshmi VS. High-Sensitivity C-Reactive Protein-to-Albumin Ratio in Predicting the Major Adverse Cardiovascular Event in Acute Coronary Syndrome at Presentation. Indian Journal of Cardiovascular Disease in Women. 2022;7(3):130–136. doi: 10.25259/mm_ijcdw_441
  60. Arques S, Roux E, Sbragia P, Gelisse R, Pieri B, Ambrosi P. Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study. Int J Cardiol. 2008;125(2):265–267. doi: 10.1016/j.ijcard.2007.07.094
  61. Grimm G, Haslacher H, Kampitsch T, et al. Sex differences in the association between albumin and all-cause and vascular mortality. Eur J Clin Invest. 2009;39(10):860–865. doi: 10.1111/j.1365-2362.2009.02189.x
  62. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during. Findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1(5):e259–81. doi: 10.1016/S2214-109X(13)70089-5
  63. Shevtsova A, Gordiienko I, Tkachenko V, Ushakova G. Ischemia-Modified Albumin: Origins and Clinical Implications. Dis Markers. 2021;19:9945424. doi: 10.1155/2021/9945424
  64. Babu MS, Kaul S, Dadheech S, Rajeshwar K, Jyothy A, Munshi A. Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition. 2013;29(6):872–875. doi: 10.1016/j.nut.2012.12.015
  65. Joanna B, Jacek K, Elżbieta CC, et al. Worse Neurological State During Acute Ischemic Stroke is Associated with a Decrease in Serum Albumin Levels. J Mol Neurosci. 2016;58(4):493–496. doi: 10.1007/s12031-015-0705-4
  66. Boselli M, Aquilani R, Baiardi P, et al. Supplementation of essential amino acids may reduce the occurrence of infections in rehabilitation patients with brain injury. Nutr Clin Pract. 2012;27(1):99–113. doi: 10.1177/0884533611431068
  67. Chen J, Fredrickson V, Ding Y, et al. Enhanced neuroprotection by local intra-arterial infusion of human albumin solution and local hypothermia. Stroke. 2013;44(1):260–262. doi: 10.1161/STROKEAHA.112.675462
  68. Defazio RA, Zhao W, Deng X, Obenaus A, Ginsberg MD. Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: a laser speckle contrast flow study. J Cereb Blood Flow Metab. 2012;32(11):2012–2022. doi: 10.1038/jcbfm.2012.102
  69. Dziedzic T, Pera J, Wnuk M, Szczudlik A, Słowik A. Serum albumin level as a determinant of cortisol release in patients with acute ischemic stroke. Atherosclerosis. 2012;221(1):212–214. doi: 10.1016/j.atherosclerosis.2011.12.017
  70. Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke. Marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke. 2001;32(2):553–560. doi: 10.1161/01.str.32.2.553
  71. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88(1):53–60. doi: 10.1136/heart.88.1.53
  72. Ballmer PE. Causes and mechanisms of hypoalbuminaemia. Clin Nutr. 2001;20(3):271–273. doi: 10.1054/clnu.2001.0439
  73. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–445. doi: 10.1146/annurev-immunol-031210-101322
  74. Marzilli M, Merz CN, Boden WE, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol. 2012;60(11):951–956. doi: 10.1016/j.jacc.2012.02.082
  75. Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60(22):2263–2270. doi: 10.1016/j.jacc.2012.04.063
  76. Zhang H, Li J, Chen X, et al. Association of systemic inflammation score with atrial fibrillation: a case-control study with propensity score matching. Heart Lung Circ. 2018;27(4):489–496. doi: 10.1016/j.hlc.2017.04.007
  77. Avram C, Gligor A, Roman D, Soylu A, Nyulas V, Avram L. Machine learning based assessment of preclinical health questionnaires. International Journal of Medical Informatics. 2023;180:105248. doi: 10.1016/j.ijmedinf.2023.105248
  78. Kenneth JM, Janne ST, Jens F, Morten G, Gorm J. Fibrinogen and Albumin Levels and Risk of Atrial Fibrillation in Men and Women (the Copenhagen City Heart Study). Am J Cardiol. 2006;98(1):75–81. doi: 10.1016/j.amjcard.2006.01.067
  79. Aquilani R, Opasich C, Verri M, et al. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol. 2003;42(7):1218–1223. doi: 10.1016/s0735-1097(03)00946-x
  80. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New Engl J Med. 2004;350(22):2247–2256. doi: 10.1056/NEJMoa040232
  81. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319–334. doi: 10.1097/01.SLA.0000055547.93484.87
  82. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85(4):599–610. doi: 10.1093/bja/85.4.599
  83. Ha CE, Bhagavan NV. Novel insights into the pleiotropic effects of human serum albumin in health and disease. Biochim Biophys Acta. 2013;1830(12):5486–5493. doi: 10.1016/j.bbagen.2013.04.012
DOI: https://doi.org/10.2478/jce-2024-0024 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 11 - 19
Submitted on: Aug 27, 2024
|
Accepted on: Sep 20, 2024
|
Published on: Mar 28, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Maria Czinege, Florina Ruța, Victoria Nyulas, Vasile-Bogdan Halațiu, Tiberiu Nyulas, Theodora Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution 3.0 License.